Advertisement

Topics

Vector Capital Company Profile

08:20 EDT 21st June 2018 | BioPortfolio

Vector Capital is a leading global private equity firm specializing in transformational investments in established technology businesses. Vector identifies and pursues these complex investments in both the private and public markets. Vector actively partners with management teams to devise and execute new financial and business strategies that materially improve the competitive standing of these businesses and enhance their value for employees, customers and shareholders. Among Vector's notable investments are 20-20 Technologies, Aladdin Knowledge Systems, Cambium Networks, Corel, Gerber Scientific, RAE Systems, LANDesk Software, Register.com, SafeNet, Technicolor, Teletrac, Tidel, WatchGuard Technologies, and WinZip.


News Articles [740 Associated News Articles listed on BioPortfolio]

GE creates ready-to-run factory for viral vector drugs

GE Healthcare has created a ‘factory-in-a-box’ facility for the production of viral vector-based drugs, including viral vector vaccines, oncolytic viruses,...Read More... The post GE creat...

[Comment] Measuring the effect of insecticide resistance: are we making progress?

Exceptional global efforts to fight malaria have greatly reduced the disease burden by more than 500 million cases since 2000 in sub-Saharan Africa.1 These gains are partly ascribed to vector control ...

#jobs #lifescience Paramount Recruitment: Viral Vector Scientist – AAV- Oxford

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Paramount Recruitment: Viral Vector Scientist – AAV- Oxford . Negotiabl...

The importance of heterogeneity on the management of vector borne diseases

Researchers have been working to look at the role that heterogeneity in mosquito biting plays within the transmission of disease and what impact vector control has on that heterogeneity. While it is w...

#jobs #lifescience Paramount Recruitment: Viral Vector Scientist- Lentiviral – Oxford

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Paramount Recruitment: Viral Vector Scientist- Lentiviral – Oxford . Ne...

Modified Adenovirus Vector Used for Cancer Gene Therapy

A team of medical virologists has modified the commonly used adenovirus vector to both avoid clearance by the immune system...

HP/Agilent 4193A Vector Impedance Meter 0.4 to 110MHz  Probe Only

$750.00End Date: Thursday May-10-2018 21:42:11 PDTBuy It Now for only: $750.00Buy It Now | Add to watch list Biotech365 : HP/Agilent 4193A Vector Impedance Meter 0.4 to 110MHz  Probe Only BioMar...

GE accelerates production of viral vector based therapeutics

GE Healthcare has launched a new factory-in-a-box, designed to accelerate the manufacture of products requiring a biosafety level 2 environment such as viral vector-based therapeutics

PubMed Articles [557 Associated PubMed Articles listed on BioPortfolio]

Changes in social capital and depressive states of middle-aged adults in Japan.

The present study examines the relationships between changes in bonding and bridging types of social capital and depressive states among middle-aged adults in Japan using a nationally representative s...

What is the association between social capital and diabetes mellitus? A systematic review.

Social capital has been included as an element that could influence the self-perception of health, mortality and mental diseases. We systematically reviewed papers that studied the influence of social...

The dark side of social capital: A systematic review of the negative health effects of social capital.

There is a growing literature demonstrating the health benefits of social capital (defined as the resources accessed through social connections). However, social capital is also acknowledged to be a "...

Social Capital and Health Among Older Chinese Immigrants: a Cross-Sectional Analysis of a Sample in a Canadian Prairie City.

The objective of this study was to examine the relationship between social capital and health among Chinese immigrants. The sample included 101 older Chinese immigrants aged 60 to 96 who were recruite...

"Who'll do all these if I'm not around?": Bonding social capital and health and well-being of inpatients.

Although social capital influences health-related decisions and behavioural patterns in many developing countries, minimal attention has been paid to the nuances of its effect on healthcare. This pape...

Clinical Trials [254 Associated Clinical Trials listed on BioPortfolio]

Slipped Capital Femoral Epiphysis Treatment

Slipped capital femoral epiphysis represents approximately 10.8 cases per 100,000 children. The primary source for the blood supply of the head of the femur is the deep branch of the media...

Phase I Randomized Study of Adeno-Associated Virus-CFTR Vector in Patients With Cystic Fibrosis

OBJECTIVES: I. Determine the maximum tolerated dose of recombinant adeno-associated virus-CFTR vector in patients with cystic fibrosis. II. Assess the safety of this gene therap...

Study of Intra-articular Delivery of tgAAC94 in Inflammatory Arthritis Subjects

The 13G01 clinical trial is a Phase I/II dose escalation study designed to be conducted in adults with inflammatory arthritis who have persistent moderate or severe swelling in one or more...

The Montreal Neighbourhood Networks and Healthy Aging Panel

Social networks, social capital, i.e., network-accessed resources, and neighbourhood environments have been shown associated with a range of health behaviours and conditions, including obe...

Implementation Research of New Dengue Vector Control Tools

This project will provide new insights concerning how to reduce dengue transmission by means of cost-effective and sustainable implementation strategies of vector control methods. The res...

Companies [1116 Associated Companies listed on BioPortfolio]

Vector Capital

Vector Capital is a leading global private equity firm specializing in transformational investments in established technology businesses. Vector identifies and pursues these compl...

Bavarian Nordic A/S

In 2004 we marked our 10 year anniversary as a company. Over the past decade we have developed the early MVA vector research into a broad commercial vaccine vector technology.

SIRION Biotech GmbH

Founded in 2005, SIRION Biotech is a global leader in developing research and commercial grade viral vector solutions for industry and academic partners who are developing gene th...

Genethon

Genethon produces recombinant viral vectors for gene transfer. The vectors can be used for research or preclinical studies. GMP grade vector preparations will be available in the near future.We can ei...

Cynvec LLC

Cynvec, a privately held biotechnology company, is developing proprietary cancer therapies based on the apoptotic sindbis oncolytic viral vector, a novel technology that targets the over expressed lam...

More Information about "Vector Capital" on BioPortfolio

We have published hundreds of Vector Capital news stories on BioPortfolio along with dozens of Vector Capital Clinical Trials and PubMed Articles about Vector Capital for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Vector Capital Companies in our database. You can also find out about relevant Vector Capital Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record